NHERF-1 regulation of EGF and neurotensin signalling in HT-29 epithelial cells

Biochemical and Biophysical Research Communications

Volumn 432, Issue 4, 2013, Pages 568-573

  Kruger, Wade A ^a   Monteith, Gregory R ^b   Poronnik, Philip ^a,c  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Calcium; Epithelial growth factor; G protein; Neurotensin; PDZ scaffold

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; NEUROTENSIN; SODIUM PROTON EXCHANGE PROTEIN 1;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HT29; COLON ADENOCARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; MITOGENICITY; MOLECULAR MECHANICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

CALCIUM SIGNALING; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; GENE KNOCKDOWN TECHNIQUES; HT29 CELLS; HUMANS; NEUROTENSIN; PHOSPHOPROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; URIDINE TRIPHOSPHATE;

EID: 84875513348     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.047     Document Type: Article

References (37)

1. Briviba K., Abrahamse S.L., Pool-Zobel B.L., Rechkemmer G. Neurotensin- and EGF-induced metabolic activation of colon carcinoma cells is diminished by dietary flavonoid cyanidin but not by its glycosides. Nutr. Cancer 2001, 41:172-179.
2. Hassan S., Carraway R.E. Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth. Regul. Pept. 2006, 133:105-114.
3. Kisfalvi K., Guha S., Rozengurt E. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells. J. Cell Physiol. 2005, 202:880-890.
4. Georgescu M.M., Morales F.C., Molina J.R., Hayashi Y. Roles of NHERF1/EBP50 in cancer. Curr. Mol. Med. 2008, 8:459-468.
5. Bellizzi A., Malfettone A., Cardone R.A., Mangia A. NHERF1/EBP50 in breast cancer: clinical perspectives. Breast Care (Basel) 2010, 5:86-90.
6. Fraenzer J.T., Pan H., Minimo L., Smith G.M., Knauer D., Hung G. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Int. J. Oncol. 2003, 23:1493-1500.
7. Shibata T., Chuma M., Kokubu A., Sakamoto M., Hirohashi S. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003, 38:178-186.
8. Nielsen J.S., Graves M.L., Chelliah S., Vogl A.W., Roskelley C.D., McNagny K.M. The CD34-related molecule podocalyxin is a potent inducer of microvillus formation. PLoS One 2007, 2:e237.
9. Morales F.C., Takahashi Y., Kreimann E.L., Georgescu M.M. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia. Proc. Natl. Acad. Sci. USA 2004, 101:17705-17710.
10. Hayashi Y., Molina J.R., Hamilton S.R., Georgescu M.M. NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia 2010, 12:1013-1022.
11. Brone B., Eggermont J. PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. Am. J. Physiol. Cell Physiol. 2005, 288:C20-29.
12. Weinman E.J., Hall R.A., Friedman P.A., Liu-Chen L.Y., Shenolikar S. The association of NHERF adaptor proteins with g protein-coupled receptors and receptor tyrosine kinases. Annu. Rev. Physiol. 2006, 68:491-505.
13. +-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF. Biochem. J. 2003, 376:505-510.
14. + exchange. Nature 1998, 392:626-630.
15. + exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface. Mol. Biol. Cell 2004, 15:5470-5480.
16. Suh P.G., Hwang J.I., Ryu S.H., Donowitz M., Kim J.H. The roles of PDZ-containing proteins in PLC-beta-mediated signaling. Biochem. Biophys. Res. Commun. 2001, 288:1-7.
17. Rochdi M.D., Watier V., La Madeleine C., Nakata H., Kozasa T., Parent J.L. Regulation of GTP-binding protein alpha q (Galpha q) signaling by the ezrin-radixin-moesin-binding phosphoprotein-50 (EBP50. J. Biol. Chem. 2002, 277:40751-40759.
18. Kreimann E.L., Morales F.C., de Orbeta-Cruz J., Takahashi Y., Adams H., Liu T.J., McCrea P.D., Georgescu M.M. Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 2007, 26:5290-5299.
19. Takahashi Y., Morales F.C., Kreimann E.L., Georgescu M.M. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J. 2006, 25:910-920.
20. Zhao D., Zhan Y., Koon H.W., Zeng H., Keates S., Moyer M.P., Pothoulakis C. Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J. Biol. Chem. 2004, 279:43547-43554.
21. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402:884-888.
22. Carraway R.E., Plona A.M. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides 2006, 27:2445-2460.
23. Iwase K., Evers B.M., Hellmich M.R., Kim H.J., Higashide S., Gully D., Thompson J.C., Townsend C.M. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692. Cancer 1997, 79:1787-1793.
24. Zhao D., Zhan Y., Zeng H., Koon H.W., Moyer M.P., Pothoulakis C. Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells. Int. J. Cancer 2007, 120:1652-1656.
25. Xu H., Yu Y., Marciniak D., Rishi A.K., Sarkar F.H., Kucuk O., Majumdar A.P. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells. Mol. Cancer Ther. 2005, 4:435-442.
26. Morinville A., Martin S., Lavallee M., Vincent J.P., Beaudet A., Mazella J. Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells. Int. J. Biochem. Cell biol. 2004, 36:2153-2168.
27. Sullivan S.M., Lee A., Bjorkman S.T., Miller S.M., Sullivan R.K., Poronnik P., Colditz P.B., Pow D.V. Cytoskeletal anchoring of GLAST determines susceptibility to brain damage: an identified role for GFAP. J. Biol. Chem. 2007, 282:29414-29423.
28. 2+-ATPase involves PSD-95/Dlg/Zo-1-mediated interactions. J. Biol. Chem. 2009, 284:1820-1830.
29. Lamprecht G., Weinman E.J., Yun C.H. The role of NHERF and E3KARP in the cAMP-mediated inhibition of NHE3. J. Biol. Chem. 1998, 273:29972-29978.
30. 2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells. PLoS One 2011, 6:e23464.
31. Hassan S., Dobner P.R., Carraway R.E. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of neurotensin on DNA synthesis in PC3 cells. Regul. Pept. 2004, 120:155-166.
32. Hermans E., Maloteaux J.M. Mechanisms of regulation of neurotensin receptors. Pharmacol. Ther. 1998, 79:89-104.
33. Ritter S.L., Hall R.A. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat. Rev. Mol. Cell Biol. 2009, 10:819-830.
34. Rochdi M.D., Parent J.L. Galphaq-coupled receptor internalization specifically induced by Gα signaling. Regulation by EBP50. J. Biol. Chem. 2003, 278:17827-17837.
35. Cummins M.M., O'Mullane L.M., Barden J.A., Cook D.I., Poronnik P. Purinergic responses in HT29 colonic epithelial cells are mediated by G protein alpha-subunits. Cell Calcium 2000, 27:247-255.
36. Massa F., Tormo A., Beraud-Dufour S., Coppola T., Mazella J. Neurotensin-induced Erk1/2 phosphorylation and growth of human colonic cancer cells are independent from growth factors receptors activation. Biochem Biophys Res Commun 2011, 414:118-122.
37. Muller K.M., Tveteraas I.H., Aasrum M., Odegard J., Dawood M., Dajani O., Christoffersen T., Sandnes D.L. Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells. BMC Cancer 2011, 11:421.